-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Macrogenics, Raises Price Target to $4

Benzinga·03/10/2026 14:17:25
Listen to the news
Barclays analyst Etzer Darout maintains Macrogenics (NASDAQ:MGNX) with a Overweight and raises the price target from $3 to $4.